Skip to main content

Phase II Pilot Trial of an Indoleamine 2, 3,diosygenase -1 (IDO1) Inhibitor (INCBO24360) Plus a Multipeptide Melanoma Vaccine (MELTAC 12.1) in Patients with Advanced Melanoma (CITN-04)

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Medical Oncology

Awarded By

Fred Hutchinson Cancer Research Center

Start Date

September 21, 2017

End Date

August 31, 2018
 

Administered By

Medicine, Medical Oncology

Awarded By

Fred Hutchinson Cancer Research Center

Start Date

September 21, 2017

End Date

August 31, 2018